Found: 10
Select item for more details and to access through your institution.
Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Large-Scale Growth of Mouse P815 Cells Expressing a Bovine Non-Classical Major Histocompatibility Complex Class I Protein Utilizing a Pitched-Blade Bioreactor.
- Published in:
- BioProcessing Journal, 2012, v. 11, n. 3, p. 27
- By:
- Publication type:
- Article
Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.773999
- By:
- Publication type:
- Article
On crushing of deutetrabenazine tablets.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Optimising the collaborative practice of nurses in primary care settings using a knowledge translation approach.
- Published in:
- Evidence & Policy: A Journal of Research, Debate & Practice, 2016, v. 12, n. 4, p. 605, doi. 10.1332/174426415X14399915315420
- By:
- Publication type:
- Article
Pandemic lineage 2009 H1N1 influenza A virus infection in farmed mink in Utah.
- Published in:
- Journal of Veterinary Diagnostic Investigation, 2022, v. 34, n. 1, p. 82, doi. 10.1177/10406387211052966
- By:
- Publication type:
- Article
Opisthotonos and unilateral internal hydrocephalus associated with aberrant migration of Serratospiculum sp. or Serratospiculoides sp. in a prairie falcon.
- Published in:
- Journal of Veterinary Diagnostic Investigation, 2018, v. 30, n. 5, p. 770, doi. 10.1177/1040638718777284
- By:
- Publication type:
- Article
Increased expression of pro‐inflammatory cytokines at the fetal–maternal interface in bovine pregnancies produced by cloning.
- Published in:
- American Journal of Reproductive Immunology, 2022, v. 87, n. 3, p. 1, doi. 10.1111/aji.13520
- By:
- Publication type:
- Article
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 3, p. 655, doi. 10.1007/s40120-024-00600-1
- By:
- Publication type:
- Article
Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 5, p. 2249, doi. 10.1007/s12325-023-02455-8
- By:
- Publication type:
- Article